Management of Advanced NSCLC
EP. 1: Case 1: Locally Advanced Squamous Non-Small Cell Lung Cancer
September 12th 2018
EP. 2: Case 1: Immunotherapy in Locally Advanced NSCLC
September 12th 2018
EP. 3: Case 1: Molecular Testing in Locally Advanced NSCLC
September 12th 2018
EP. 4: Case 1: Consolidation Therapy in Locally Advanced NSCLC
September 12th 2018
EP. 5: Case 1: I-O Therapy & Autoimmune Conditions in NSCLC
September 12th 2018
EP. 6: Case 2: Stage IV PD-L1-Negative, KRAS-Mutant Lung Adenocarcinoma
September 12th 2018
EP. 7: Case 2: Frontline Treatment Data in Stage IV NSCLC
September 12th 2018
EP. 8: Case 2: Biomarkers and Treatment Decisions in Stage IV NSCLC
September 12th 2018
EP. 9: Case 2: Treatment Considerations in Stage IV NSCLC
September 12th 2018
EP. 10: Case 3: Rapidly Progressing Stage IV NSCLC Following I-O
September 12th 2018
EP. 11: Case 3: Tissue & Plasma Sampling in Stage IV NSCLC
September 12th 2018
EP. 12: Case 3: Second-Line Therapy After Chemo/I-O in Stage IV NSCLC
September 12th 2018
EP. 13: Case 3: Considerations for Second-Line Therapy in Stage IV NSCLC
September 12th 2018
EP. 14: Case 4: Metastatic EGFR+ NSCLC Progressing on Osimertinib
September 12th 2018
EP. 15: Case 4: Upfront Osimertinib in Metastatic EGFR+ NSCLC
September 12th 2018
EP. 16: Case 4: EGFR Mutation Analysis Post-Osimertinib
September 12th 2018
EP. 17: Case 4: Treating EGFR+ NSCLC After Osimertinib
September 12th 2018
